SEC Form 4 · accession 0000950157-16-002181
Evolent Health, Inc. · EVH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steve Wigginton
Officer — Chief Development Officer
Period of report
Sep 14, 2016
Accepted (ET)
Sep 15, 2016 · 4:56 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001628908
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common StockF1 | Sep 14, 2016 | S | 45,760 | $21.54 | D | 359,692 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price of $21.54 represents the public offering price of $22.50 per share of Class A Common Stock less the underwriters' discount of $0.96 per share.
Remarks
Exhibit 24.1 Power of Attorney dated June 16, 2015